Search Results (243)

Droplet manipulation constitutes a fundamental operation in numerous bio-microfluidic applications, including but not limited to medical diagnostics and targeted drug delivery. Among the various technologies developed for this purpose, magnetic digital microfluidics (MDMF) has emerged as a compelling approach due to its inherent advantages of contamination-free actuation, low cost, and configurational flexibility. Nevertheless, conventional MDMF remains constrained by its reliance on bulky instrumentation and substantial power consumption for generating controllable magnetic fields, which limit its in-field applications. To address these limitations, this work presents a programmable and portable electromagnetic microfluidic droplet manipulation platform that synergistically integrates static and dynamic magnetic fields to enable non-contact, high-precision droplet control under ultra-low power conditions. The proposed system comprises an electromagnetic actuation module, a permanent magnet, and a glass substrate coated with Teflon film. The entire system is secured by a PMMA support structure, within which a glass substrate is mounted and spatially separated from the permanent magnet. The PMMA support is fabricated using a milling process, offering a simple manufacturing procedure and high structural reusability and reproducibility. The control logic is implemented on a field-programmable gate array (FPGA) development board, facilitating fully autonomous operation powered by a standard battery. The platform operates at a low voltage of 3.5 V and a driving current of 180 mA, corresponding to a total power consumption of merely 0.63 W, while achieving robust manipulation of droplets in the volume range of 0.5 to 5 μL. A maximum average droplet velocity of up to 0.6 cm/s was attained under optimal conditions. The proposed platform offers a scalable and energy-efficient solution for portable droplet-based assays and holds significant promise for integration into point-of-care diagnostic tools and field-ready biochemical analysis systems. The platform demonstrates excellent operational stability and reproducibility, as validated by repeated actuation experiments with a positioning deviation of approximately 0.1 mm under optimized conditions. The fabrication process also exhibits high reliability with consistent performance across multiple experimental runs. Full article

Sustainable nanotechnologies derived from renewable resources are increasingly being positioned at the interface of green chemistry, advanced drug delivery, and translational pharmaceutics. Over the past decade, lignocellulosic nanomaterials, chitin/chitosan platforms, polysaccharide-based nanogels and nano-enabled hydrogels, lignin- and polyphenol-derived nanostructures, and bio-based lipid nanocarriers have been engineered through progressively eco-efficient routes, including solvent-minimized self-assembly, nanoprecipitation, spray drying, hot-melt extrusion, and microfluidic-assisted fabrication. This work provides a structured evidence map of nano-enabled drug delivery and therapeutic platforms derived from renewable biological resources. Specifically, we aim to (i) identify and classify nanoplatform classes and renewable feedstocks; (ii) summarize reported pharmaceutical critical quality attributes (CQAs) and performance and safety endpoints; and (iii) appraise how “renewability” and “green” claims are evidenced (feedstock origin vs. process sustainability) and how frequently translational readiness factors (scalability, quality control, regulatory alignment) are addressed. We critically compare renewable and conventional nanomaterial platforms across key translational dimensions, including carbon footprint, batch consistency, biodegradability, functional tunability, safety/persistence, and scale-up maturity. Finally, we delineate a practical translational pathway—from biomass sourcing and fractionation to nanoformulation, characterization/stability, and GMP scale-up—highlighting cross-cutting enablers such as lifecycle assessment, EHS/toxicology risk assessment, quality-by-design, and regulatory alignment. Collectively, the evidence supports renewable nanomaterials as viable, scalable candidates for next-generation therapeutics, provided that variability control, standardized characterization, and safety-by-design principles are embedded early in development. Full article

Water purification and treatment methods are becoming increasingly complex due to the use of new additives, solvents, pesticides, dyes, and other emerging pollutants in industry, agriculture, and households. Consequently, the search for new water treatment techniques and materials that can help reduce this environmental impact has become a major focus in the field of green chemistry. In this work, the photocatalytic degradation capacity of composites containing TiO₂ nanoparticles (TNPs) for the removal of organic pollutants in water was studied. The TNPs were immobilized in bio-based hydrogel microparticles, which were prepared using microfluidic techniques. The composition of the dispersed phase was optimized with a lab-on-a-chip device, resulting in composite microparticles with a narrow size distribution. UV–visible spectroscopy results indicated that increasing the concentration of TNPs in the hydrogel microparticles enhanced the photodegradation performance of the new composite. Remarkably, it was able to efficiently degrade nearly 90% of reference dyes after four adsorption–desorption cycles. Full article

Three-dimensional (3D) cultured cells can mimic the in vivo tumor microenvironment more accurately than conventional monolayer cultures. Therefore, they are essential in cancer research and drug discovery. However, high-sensitivity fluorescence imaging of 3D spheroids remains challenging owing to their limited contact with the observation surface and the low penetration depth of total internal reflection fluorescence microscopy (TIRFM). In this study, we developed a microfluidic device equipped with a water-driven balloon actuator that enables the hydrostatic compression of 3D-cultured spheroids. This system gently presses spheroids against a glass surface, significantly enhancing the contact area and improving TIRFM and epifluorescence imaging quality, with more evident improvement observed in TIRFM. Our results show that hydrostatic compression markedly enhances optical accessibility in spheroids while preserving cell viability and structural integrity. The method is designed to complement volumetric imaging techniques, including confocal and light-sheet microscopy, by enabling high-contrast visualization of cell–surface molecular dynamics. Although the current system focuses on surface accessibility, future studies will incorporate rotational mechanisms and automated pressure control to facilitate multi-angle, high-throughput imaging. This platform offers a promising strategy for the dynamic observation of cell–surface interactions in living 3D systems. Full article

In this research, an innovative scheme to generate heterogeneous acoustofluidic distributions in various pseudo-Sierpiński-carpet-shaped chambers with different filling fractions and cross-sectional configurations has been proposed and calculated for topographical manipulation of large-scale micro-particles. All of the structural components positioned in the pseudo-fractal chambers are symmetrically distributed in space, and all ultrasonic radiation surfaces hold the unified settings of input frequency point, oscillation amplitude, and initial phase distribution along their respective normal directions. A large number of fascinating acoustofluidic patterns can be generated in the originally-static pseudo-Sierpiński-carpet-shaped chambers at different recursion levels without complicated vibration parameter modulation. The simulation results of acoustofluidic distributions and particle motion trajectories under different radiation surface arrangements further demonstrate the manipulation performance of these specially designed devices, and indicate that controllable spatial partitioning and intensity modulation of the acoustofluidic field can be achieved by adjusting the hierarchical order, cross-sectional configuration and combination mode of the radiation surfaces. Unlike the existing device construction method of miniaturized microfluidic systems, the artificial introduction of fractal elements like Sierpiński carpet/triangle, Koch snowflake, Mandelbrot set, Pythagoras tree, etc., can provide extraordinary perspectives and expand the application range of the acoustofluidic effect, which also makes ultrasonic micro/nano-scale manipulation technology more abundant and diversified. This exploratory research indicates the potential possibility of applying fractal structures as alternative component parts to purposefully customize acoustofluidic distributions for the further research of patterned manipulation of bio-organisms and navigation of micro-robot swarms in brand new ways that cannot be achieved through traditional methods. Full article

Aberrant activation of the RAS signaling pathway is a halmark of various cancers. This activation, is often caused by mutations in RAS genes or other pathway components and, drivesi uncontrolled cell growth and proliferation. Studies have demonstrated that certain codon mutations can significantly influence the clinical outcomes of cancer patients. Historically, KRAS was considered “undruggable”; however, recent advancements in drug discovery have led to the development of promising KRAS inhibitors. Accurately identifying the specific type of KRAS mutation in a patient is essential for making optimal treatment decisions. Several methods have been developed for detecting KRAS mutations to address this need, focusing on creating robust, rapid, sensitive, accurate, and cost-effective approaches, particularly for point-of-care applications. Starting with the Ras family and RASopathies, this review provides a comprehensive overview of KRAS mutation detection methods, ranging from research-use-only techniques to in vitro diagnostic-certified tests. Published results are critically evaluated in terms of accuracy, sensitivity, cost, throughput, and suitability for various sample types and clinical settings. This, offers researchers and clinicians an up-to-date resource for. Full article

Smart vesicle therapeutics represent a transformative frontier in nanomedicine, offering precise, biocompatible, and adaptable platforms for drug delivery and theranostic applications. This review explores recent advances in the design and engineering of liposomes, niosomes, polymersomes, and extracellular vesicles (EVs), emphasizing their capacity to integrate therapeutic and diagnostic functions within a single nanoscale system. By tailoring vesicle size, composition, and surface chemistry, researchers have achieved improved pharmacokinetics, reduced immunogenicity, and fine-tuned control of drug release. Stimuli-responsive vesicles activated by pH, temperature, and redox gradients, or external fields enable spatiotemporal regulation of therapeutic action, while hybrid bio-inspired systems merge synthetic stability with natural targeting and biocompatibility. Theranostic vesicles further enhance precision medicine by allowing real-time imaging, monitoring, and adaptive control of treatment efficacy. Despite these advances, challenges in large-scale production, reproducibility, and regulatory standardization still limit clinical translation. Emerging solutions—such as microfluidic manufacturing, artificial intelligence-guided optimization, and multimodal imaging integration—are accelerating the development of personalized, high-performance vesicular therapeutics. Altogether, smart vesicle platforms exemplify the convergence of nanotechnology, biotechnology, and clinical science, driving the next generation of precision therapies that are safer, more effective, and tailored to individual patient needs. Full article

Pineapple leaf fibers (PALFs), obtained from abundant yet underutilized pineapple leaf residues, represent a promising feedstock for producing fibrillated cellulose. In this work, cellulosic fibers were isolated and characterized by Fiber Quality Analysis (FQA), showing lengths between 0.33 and 0.47 mm and widths of 12.2 µm after organosolv pulping using ethanol and acetic acid as a catalyst, followed by hydrogen peroxide bleaching with diethylenetriaminepentaacetic acid as a chelating agent. The cellulosic fibers were then subjected to TEMPO-mediated oxidation and subsequently disintegrated by microfluidization to produce micro-/nanofibrillated cellulose (MNFC) with a carboxylate content of 0.85 and 1.00 mmol COO⁻/g, zeta potential of −41 and −53 mV, and average widths of 15 and 12 nm for unbleached and bleached nanofibrils, respectively. The nanofibrillation yields were 73% and 68% for the bleached and unbleached MNFC samples, indicating the presence of some non-fibrillated or partially fibrillated fractions. X-ray diffraction analysis confirmed preservation of cellulose type I crystalline structure, with increased crystallinity, reaching 85% in the bleached MNFC. These findings demonstrate the feasibility of a sequential process, combining organosolv pulping, hydrogen peroxide bleaching, TEMPO-mediated oxidation, and microfluidization, for preparing MNFC from pineapple leaf fibers. Overall, this study highlights pineapple leaf residues as a sustainable source of MNFC, supporting strategies to transform agricultural waste into valuable bio-based materials. Full article

Traditionally, fuel cells operate by using small fuel molecules such as hydrogen and methanol to produce energy, water, and carbon dioxide. Enzyme biofuel cells use enzymes rather than precious metals as electrode catalysts. In recent years, enzyme-immobilized electrodes have been developed by combining enzyme biofuel cells with microfluidic technology to improve the efficiency and performance of fuel cells. In this review, we will provide an overview and describe the current status of recent enzyme biofuel cells, microfluidic technology, and their applications to microfluidic fuel cells. Full article

The rapid rise of antibiotic-resistant bacteria (ABR) presents an urgent global health challenge, necessitating the development of efficient and scalable diagnostic technologies. Electrochemical biosensors have emerged as a promising solution, offering high sensitivity, specificity, and adaptability for point-of-care applications. These innovative platforms utilize bio-recognition elements, advanced electrode materials, microbial enzymes, and redox-active metabolites to identify antibiotic resistance profiles at a molecular level. Recent progress in microfluidics and lab-on-a-chip systems has enabled real-time, high-throughput antimicrobial susceptibility testing, significantly improving diagnostic precision and speed. This review aims to critically evaluate recent advances in electrochemical biosensing strategies for detecting ABR, identify key challenges, and propose future directions to enhance clinical applicability. Key developments include bio-receptor-based detection strategies, novel electrode surfaces, and multiplexed platforms integrated with microfluidic systems. Additionally, this review examines essential biomarkers for detecting antibiotic resistance and explores key challenges, including variability in biomarker expression and sensor reproducibility. It also highlights practical barriers to clinical implementation, such as cost constraints and scalability concerns. By presenting innovative approaches, such as cost-effective material alternatives, advanced analytical techniques, and portable biosensing systems, this review outlines a strategic pathway for enhancing the accessibility and effectiveness of electrochemical biosensors in antibiotic resistance management. Full article

Blood is a widely used sample for diagnosing diseases such as malaria and diabetes. While diagnostic techniques have advanced, sample preparation remains labor-intensive, requiring steps like mixing and centrifugation. Microfluidic technologies have automated parts of this process, including cell lysis, yet challenges persist. Electrical lysis offers a chemical-free, continuous approach, but lysing small cells like red blood cells requires high electric fields, which can damage electrodes and cause system failures. Here, we present a microfluidic device utilizing ion concentration polarization (ICP) for rapid blood cell lysis at 75 V. Fluorescence imaging confirmed the formation of an ion depletion region near the Nafion^® nanochannel membrane, where the electric field was concentrated across the entire microchannel width. This phenomenon enabled the efficient trapping and lysis of blood cells under these conditions. Continuous blood injection achieved a lysis time of 0.3 s with an efficiency exceeding 99.4%. Moreover, lysed cell contents accumulated near the Nafion membrane, forming a concentrated lysate. This approach eliminates the need for high-voltage circuits or chemical reagents, offering a simple yet effective method for blood cell lysis. The proposed device is expected to advance lab-on-a-chip and point-of-care diagnostics by enabling rapid and continuous sample processing. Full article

Conventional laboratory methods for handling valuable biological samples typically use pipettes or needles, which are prone to issues such as dead volume and sample waste. Furthermore, the sampling and processing of pathogenic bacteria, such as Escherichia coli (E. coli) in environmental wastewater, require labor-intensive procedures with multiple complex steps. To overcome these limitations, we developed a pipette integrated with a microfluidic chip for bacteria sampling and delivery. This pipette can provide the negative pressure to microfluidic chips for sampling, the constant temperature unit for biological reaction, and programs for automatic control (suction, heating, liquid discharge, and cleaning) and display. The droplet chip employs a cross-channel structure to generate droplets and incorporates a designated droplet storage and detection area. Utilizing this innovative device, we have demonstrated the generation, transportation, and storage of pL droplets, as well as quantitatively detected E. coli samples across various concentrations. The test results have demonstrated the overall reliability and data consistency of the system. Overall, our device achieves the precise sampling of pL volumes, offering a simple yet promising solution for the sampling and delivery of bio-samples in remote settings. Full article

Microfluidics-based mixing methods have attracted increasing attention due to their great potential in bio-related and material science fields. The combination of acoustics and microfluidics, called acoustofluidics, has been shown to be a promising tool for precise manipulation of microfluids and micro-objects. In general, achieving robust mixing performance in an efficient and simple manner is crucial for microfluidics-based on-chip devices. When surface acoustic waves (SAWs) are introduced into microfluidic devices, the acoustic field can drive highly controllable acoustic streaming flows through acoustofluidic interactions with micro-solid structures, which have the advantages of label-free operation, flexible control, contactless force, fast-response kinetics, and good biocompatibility. Therefore, the design and application of various SAW micromixers have been demonstrated. Herein, we present a comprehensive overview of the latest research and development of SAW-based micromixers. Specifically, we discuss the design principles and underlying physics of SAW-based acoustic micromixing, summarize the distinct types of existing SAW micromixers, and highlight established applications of SAW micromixing technology in chemical synthesis, nanoparticle fabrication, cell culture, biochemical analysis, and cell lysis. Finally, we present current challenges and some perspectives to motivate further research in this area. The purpose of this work is to provide an in-depth understanding of SAW micromixers and inspire readers who are interested in making some innovations in this research field. Full article

The controllable transport of droplets on solid surfaces is crucial for many applications, from water harvesting to bio-analysis. Herein, we propose a novel droplet transport controlling method, reconfigurable orbital electrowetting (ROEW) on inclined slippery liquid-infused porous surfaces (SLIPS), which enables controllable transport and dynamic handling of droplets by non-contact reconfiguration of orbital electrodes. The flexible reconfigurability is attributed to the non-contact wettability modulation and reversibly deformable flexible electrodes. ROEW graphically customizes stable wettability pathways by real-time and non-contact printing of charge-orbit patterns on SLIPS to support the continuous transport of droplets. Benefiting from the fast erase-writability of charges and the movability of non-contact electrodes, ROEW enables reconfiguration of the wetting pathways by designing electrode shapes and dynamically switching electrode configurations, achieving controllable transport of various pathways and dynamic handling of droplet sorting and mixing. ROEW provides a new approach for reconfigurable, electrode-free arrays and reusable microfluidics. Full article

The rapid development of microfluidics has driven innovations in material engineering, particularly through its ability to precisely manipulate fluids and cells at microscopic scales. Microfluidic biomaterials, a cutting-edge interdisciplinary field integrating microfluidic technology with biomaterials science, are revolutionizing biomedical research. This review focuses on the functional design and fabrication of organ-on-a-chip (OoAC) platforms via 3D bioprinting, explores the applications of biomaterials in drug delivery, cell culture, and tissue engineering, and evaluates the potential of microfluidic systems in advancing personalized healthcare. We systematically analyze the evolution of microfluidic materials—from silicon and glass to polymers and paper—and highlight the advantages of 3D bioprinting over traditional fabrication methods. Currently, despite significant advances in microfluidics in medicine, challenges in scalability, stability, and clinical translation remain. The future of microfluidic biomaterials will depend on combining 3D bioprinting with dynamic functional design, developing hybrid strategies that combine traditional molds with bio-printed structures, and using artificial intelligence to monitor drug delivery or tissue response in real time. We believe that interdisciplinary collaborations between materials science, micromachining, and clinical medicine will accelerate the translation of organ-on-a-chip platforms into personalized therapies and high-throughput drug screening tools. Full article